Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...

In a major strategic move to redefine rural healthcare delivery, state government MoU project Digital Doctor Clinic (DDC), a pioneering tech-enabled healthcare initiative, today announced the ...

The supplementary care model encourages use of health tech to boost patient outcomes for prevalent chronic conditions in Medicare patients. This month sees the start of a new Centers for Medicare & ...

For adults with type 2 diabetes mellitus (T2DM), bofanglutide, a glucagon-like peptide-1 receptor agonist, is associated with ...

Adults with type 2 diabetes who were provided medically tailored healthy meals and lifestyle counseling for 6 months had a ...

Accurate glycemic-monitoring and control of the patients with hyperglycemia/diabetes are essential for better patient care management. Hemoglobin A1c (HbA1c) measurements correlate with the average ...

Endogenex announced today that it completed enrollment in the ReCET clinical study of its endoscopic diabetes treatment.

For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study ...

My mother never had high BP or diabetes. But after my young sister’s sudden death, my mother (in her 50s) was diagnosed with ...

Millions managing diabetes rely on morning blood sugar checks, but this single number misses crucial fluctuations. HbA1c offers a two-to-three-month average, revealing a broader picture. However, a ...

Heart attacks are rising in younger men. Discover how chronic stress, unhealthy lifestyles, diabetes, and high cholesterol increase heart disease risk before age ...